Form 4: Usana Health Sciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Xia Ding, a Director of Usana Health Sciences Inc, reported multiple transactions in common stock on July 23, 2026.
Summary
- Option exercise/conversion: acquired 1,632 Common Stock on July 23, 2026; holds 8,882 after (Direct).
- Tax/exercise-price withholding: disposed of 604 Common Stock at $20.92 ($12,636) on July 23, 2026; holds 8,278 after (Direct).
- Option exercise/conversion: disposed of 1,632 Restricted Stock Units on July 23, 2026; holds 4,895 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Xia Ding — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Option exercise/conversion | Common Stock | 1,632 | — | — | 8,882 |
| 2026-07-23 | Tax/exercise-price withholding | Common Stock | 604 | $21 | $12.6K | 8,278 |
| 2026-07-23 | Option exercise/conversion | Restricted Stock Units | 1,632 | — | — | 4,895 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Option exercise/conversion (1,632 shares) |
| 2026-07-23 | Tax/exercise-price withholding (604 shares) |
| 2026-07-23 | Option exercise/conversion (1,632 shares) |
Keywords
insider transaction, Form 4, USNA, USANA HEALTH SCIENCES INC, neutral, Xia Ding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.